Question 47: Did the recipient receive concomitant therapy?

Concomitant therapy is therapy given to enhance the function of the cellular therapy. In cases where a recipient has both HCT and cell therapy, this question applies to the cell therapy infusion, not the HCT. If the recipient had a prior HCT and the therapy was already captured on the HCT form as being HCT prep regimen, it is not reported again. See question 48 for a list of drugs that can be given as concomitant therapy.

Question 48-49: Specify drugs: (check all that apply)

Select the drug(s) given as concomitant therapy. If the drug given is not in the list, check “other” and specify the other drug in question 49.

Question 50: Specify time point:

This question applies to the therapy as a whole, not to each individual drug. Concomitant therapy can be given simultaneously with the cellular therapy infusion or up to 24 hours after infusion (post cell therapy).

Last modified: Jan 27, 2020

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.